Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 22.9M | 23.3M | 22.3M | 17.0M |
Selling general and admin | 5.7M | 5.7M | 5.5M | 6.2M |
Other operating expenses | — | — | — | — |
Operating income | -28.6M | -29.0M | -27.8M | -23.2M |
Non operating interest income | ||||
Income | 1.7M | 1.6M | 2.0M | 2.3M |
Expense | — | — | — | — |
Other income expense | -36K | -24K | -37K | -25K |
Pretax income | -27.0M | -27.5M | -25.8M | -21.0M |
Tax provision | 48K | 18K | 24K | 43K |
Net income | -27.0M | -27.5M | -25.8M | -21.0M |
Basic EPS | -0.5 | -0.6 | — | -0.4 |
Diluted EPS | -0.5 | -0.6 | — | -0.4 |
Basic average shares | 58.0M | 50.1M | — | 49.7M |
Diluted average shares | 58.0M | 50.1M | — | 49.7M |
EBITDA | -28.3M | -28.7M | -27.5M | -22.9M |
Net income from continuing op. | -27.0M | -27.5M | -25.8M | -21.0M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |